Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

Clinical trial NCT03683069 · COMPLETED

Trial details

NCT number: NCT03683069
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Genetics Hypertension

Start date: 2019-01-15
Primary completion: 2023-08-28
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.